Category: Technology

How Technology can Galvanise the Unrepresented Patient Population

Posted

Participation in clinical studies is more accessible than it has ever been. This is, in large part, due to the uptake of decentralised clinical trial models, made possible by technological advancements, and accelerated by the COVID-19 pandemic.  Decentralised clinical trials leverage available technology – such as smartphones, wearables, and telehealth – to reduce the burden […]

How Technology Boosts Recruitment and Retention Rates in Clinical Trials

Posted

From travel burden to up front expenses, to juggling work and family commitments, there’s no denying that traditional site-based clinical trials place huge demand on participants. Not only do these demands contribute to high patient drop-out rates, the level of commitment often prevents patients from enrolling in vital studies in the first place. When patients […]

Decentralised Trials, Technology & Patient Engagement: SCOPE Conference 2021:

Posted

Eric and LaQuinta’s presentation focused on Decentralised Clinical Trials, Technology & Patient Engagement. They discussed how innovation, including home healthcare, home testing, telehealth and wearables, can reduce patient burden and lead to more successful trial outcomes.

Meet Our Chief Technical Officer, Neil Barfield

Posted

Passionate about the positive impact new technologies can have on clinical research and the patient experience, Neil is looking forward to a year of exciting new releases. Here, Neil gives some insight into version three of our in-house digital platform, Primarius, and shares what’s next for mdgroup’s digital products and services.

How to Involve Patients in the Design of Decentralised Clinical Trials

Posted

There’s no doubt of the seismic impact COVID-19 has had on clinical trials. As a result of safety measures, the industry has had no choice but to start moving towards an approach which minimises or eliminates the need for travel and contact. As a result, more and more trials are being held virtually, and completely decentralised trials are increasingly more common.